Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nevro Corp (NVRO)
:NVRO
Holding NVRO?
Track your performance easily
NVRO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.17 - $19.47
Previous CloseN/A
Volume192.24K
Average Volume (3M)516.48K
Market Cap
$168.62M
Enterprise Value$178.54M
Total Cash (Recent Filing)$276.36M
Total Debt (Recent Filing)$138.14M
Price to Earnings (P/E)―
Beta2.14
Next Earnings
Feb 19, 2025EPS Estimate
-0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.89
Shares Outstanding37,471,622
10 Day Avg. Volume739,748
30 Day Avg. Volume516,483
Standard Deviation0.14
R-Squared0.10
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.40
Price to Cash Flow (P/CF)15.40
P/FCF Ratio5.80
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue0.43
Enterprise Value/Gross Profit0.62
Enterprise Value/Ebitda-8.13
Forecast
1Y Price Target
$5.29Price Target Upside15.75% Upside
Rating ConsensusHold
Number of Analyst Covering11
Nevro Corp News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceNevro was able to deliver upside results with revenues exceeding the Street by 4% and the EBITDA loss coming in almost $8 million lower than consensus.
Management StrategyStock up ~20% after hours: investors encouraged by the change in management strategy going into 2025.
Product DevelopmentThe company received FDA approval and has begun a limited market release of HFX iQ with HFX AdaptivAI, which improves patient care efficiency.
Bears Say
Financial PerformanceSales came in below expectations, and full year guidance was cut, calling for double-digit declines in sales and a significantly expanded EBITDA loss.
Market CompetitionRevenues are down due to strong competition from closed-loop technology.
Revenue ChallengesThe company's revenue guidance remains below previous expectations due to struggles in the spinal cord stimulation market and competition from new entrants.
---
Ownership Overview
5.24% Insiders
20.46% Mutual Funds
1.81% Other Institutional Investors
61.19% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVRO FAQ
What was Nevro Corp’s price range in the past 12 months?
Nevro Corp lowest stock price was $3.17 and its highest was $19.47 in the past 12 months.
What is Nevro Corp’s market cap?
Nevro Corp’s market cap is $168.62M.
When is Nevro Corp’s upcoming earnings report date?
Nevro Corp’s upcoming earnings report date is Feb 19, 2025 which is in 30 days.
How were Nevro Corp’s earnings last quarter?
Nevro Corp released its earnings results on Nov 11, 2024. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.815 by $0.405.
Is Nevro Corp overvalued?
According to Wall Street analysts Nevro Corp’s price is currently Undervalued.
Does Nevro Corp pay dividends?
Nevro Corp does not currently pay dividends.
What is Nevro Corp’s EPS estimate?
Nevro Corp’s EPS estimate is -0.78.
How many shares outstanding does Nevro Corp have?
Nevro Corp has 37,471,622 shares outstanding.
What happened to Nevro Corp’s price movement after its last earnings report?
Nevro Corp reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.815. Following the earnings report the stock price went down -4.887%.
Which hedge fund is a major shareholder of Nevro Corp?
Currently, no hedge funds are holding shares in NVRO
---
Nevro Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.29 (15.75% Upside)
$5.29 (15.75% Upside)
Blogger Sentiment
Bullish
NVRO Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.16%
12-Months-Change
Fundamentals
Return on Equity
-24.78%
Trailing 12-Months
Asset Growth
6.07%
Trailing 12-Months
Company Description
Nevro Corp
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
---
NVRO Company Deck
---
NVRO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in cost management, cash position improvement, and new product launches like HFX AdaptivAI, which show promise for future growth. However, the company faced challenges with declining revenue and trial procedures, competitive pressures, and international market issues. While the company is optimistic about its strategic initiatives and new technology, market challenges remain a concern.Read More>---
NVRO Stock 12 Month Forecast
Average Price Target
$5.29
▲(15.75% Upside)
Technical Analysis
Inspire Medical Systems
―
Pulmonx
―
SI-Bone
―
Staar Surgical
―
Intuitive Surgical
―
Edwards Lifesciences
―
Best Analysts Covering NVRO
1 Year
1 Year Success Rate
10/14 ratings generated profit
1 Year Average Return
+32.48%
assigned a sell rating 2 months ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +32.48% per trade.
---